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A bacterial strain producing two antimicrobial peptides was isolated from a rhizosphere soil sample and identified
as Bacillus subtilis based on both phenotypic and 16S rRNA gene sequence phylogenetic analysis. It grew optimally
up to 14% NaCl and produced antimicrobial peptide within 24 h of growth. The peptides were purified using a
combination of chemical extraction and chromatographic techniques. The MALDI-TOF analysis of HPLC purified
fractions revealed that the strain SK.DU.4 secreted a bacteriocin-like peptide with molecular mass of 5323.9 Da and
a surface-active lipopeptide (m/z 1056 Da). The peptide mass fingerprinting of low-molecular-weight bacteriocin
exhibited significant similarity with stretches of secreted lipoprotein of Methylomicrobium album BG8 and displayed
70% sequence coverage. MALDI MS/MS analysis elucidated the lipopeptide as a cyclic lipopeptide with a β-hydroxy
fatty acid linked to Ser of a peptide with seven α-amino acids (Asp-Tyr-Asn-Gln-Pro-Asn-Ser) and assigned it to
iturin-like group of antimicrobial biosurfactants. However, it differed in amino acid composition with other
members of the iturin family. Both peptides were active against Gram-positive bacteria, suggesting that they had an
additive effect.
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Antimicrobial peptides characterization has received great
attention in the recent past due to their applications as food
preservatives without any toxic effects on host and thera-
peutic agents. At present preservation of food is a serious
concern for almost all countries across the world. Since lac-
tic acid bacteria (LAB) produce an array of antimicrobial
substances they were used as natural bio-preservatives
for special applications (Holzapfel et al. 1995; Cotter
et al. 2005; Deegan et al. 2006). Other bacteria such
as Enterococcus, Streptococcus etc., were also reported
to produce various bacteriocins and they are also being
considered for different applications. However, production
of antimicrobial peptides by Bacillus strains has been
increasingly characterized in the recent past and many pep-
tides produced by this group of bacteria found to be* Correspondence: suresh@imtech.res.in
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in any medium, provided the original work is psuitable for various applications (Abriouel et al. 2011). The
antimicrobial peptides produced by Bacillus spp., includes
various classes of bacteriocins (Klaenhammer 1993), anti-
microbial surface-active biosurfactants like lipopeptides,
glycopeptides and nonribosomally synthesized cyclic pep-
tides (Mukherjee et al. 2006; Rodrigues et al. 2006). Among
the antimicrobial biosurfactants, lipopeptides contain
peptides with 7–10 amino acid that are cyclised via a lac-
tone ring to a β-hydroxy fatty acid with different chain
lengths. The lipopeptides produced by various Bacillus
sp., are further divided into different classes such as iturins
(Delcambe et al. 1977), surfactins (Arima et al. 1968), fen-
gycins (Vanittanakom et al. 1986), kurstakins (Hathout
et al. 2000), bacillomycins (Roongsawang et al. 2002) and
mycosubtilin (Duitman et al. 1999). Among these,
iturins are the most widely reported class of lipopep-
tides produced by multiple strains of Bacillus subtilis
(Duitman et al. 1999; Isogai et al. 1982; Peypoux et al.
1986), B. licheniformis (Kakinuma et al. 1969; Yakimov
et al. 1999; Jenny et al. 1991; Lin et al. 1994) and B. cereusan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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iturin are synthesized by multifunctional enzymes encoded
by large gene clusters (Kleinkauf and von Döhren 1995;
Marahiel et al. 1997) and exhibit large diversity. Despite
the fact that multiple bacteriocins and/or lipopeptide ana-
logues are produced by a single strain, only few antimicro-
bial peptides are reported in the literature. Considering the
enormous diversity of Bacillus species in the soil ecosystem
it is very important to isolate and preserve the strains pro-
ducing these antimicrobial peptides followed by detailed
characterization. As a part of screening for biotechnologi-
cally potential soil microflora, we have earlier described a
novel bacteriocin produced by a Brevibacillus laterosporus
strain GI-9 (Singh et al. 2012). In present study we report
another antimicrobial peptide and a cyclic lipopeptide pro-
duced by a halotolerant isolate of Bacillus subtilis strain
SK.DU.4 isolated from a rhizosphere soil sample.
Material and methods
Isolation of bacteria and identification
The bacterial strain SK.DU.4 was isolated from a farm-
land soil sample. The sample was serially diluted and
plated on different media to screen the bacteria produ-
cing antimicrobial substances. Selected colonies were
streaked on to nutrient agar (NA) medium with the fol-
lowing composition (g/l): peptic digest of animal tissue,
5.0; beef extract, 1.5; yeast extract, 1.5; sodium chloride,
5.0; agar 15.0 and the pH adjusted to 7.2. The isolates
were checked for purity and preserved at −70°C for fur-
ther studies. The indicator strains used in this study
were obtained from Microbial Type Culture Collection
and Genebank (MTCC), Chandigarh, India and grown
on tryptone soya agar (TSA) medium with the following
composition (g/l): pancreatic digest of casein, 15.0;
papaic digest of soybean meal, 5.0; sodium chloride, 5.0;
agar 15.0 and the pH adjusted to 7.2. Strain SK.DU.4
was tested for various phenotypic properties including
morphology, physiology and biochemical characteristics,
according to the standard procedures. To confirm the
identification of strain SK.DU.4, the 16S rRNA gene was
amplified by PCR using universal primers and the ampli-
fied PCR product was sequenced as described earlier
(Suresh et al. 2006). The 16S rRNA gene sequences of
closely related strains were retrieved from EzTaxon
server and aligned using CLUSTAL_W program of
MEGA version 5.0 (Tamura et al. 2011). The alignment
was corrected manually using BioEdit sequence alignment
editor (Hall, 1999). Upon calculating the pair-wise evolu-
tionary distances (Kimura, 1980), a neighbour-joining
phylogenetic tree was constructed using the MEGA ver-
sion 5.0.The strain was deposited at Microbial Type
Culture Collection and Genebank, (MTCC 11460)
and the 16S rRNA gene sequence was submitted to
EMBL (HF544505) database.Determination of bacteriocin activity
The bacteriocin activity was determined by well diffusion
assay. The strain was grown for 24 h in 200 ml nutrient
broth (NB, Himedia) using 500 ml flask and subse-
quently cells were removed by centrifugation (8000 rpm
for 20 min, 4°C). The supernatant obtained was filtered
by using 0.22 μm filter (Millipore), diluted by two fold
and used to test the activity as mentioned earlier (Singh
et al. 2012). The antimicrobial peptide production was
also tested by growing the strain in minimal medium.
To examine the antimicrobial activity, S. aureus cells
were processed for scanning electron micrograph (SEM)
as described by earlier (Singh et al. 2012). Growth curve
was prepared to examine the bacteriocin production
along with the growth of strain SK.DU4.
Production and purification of bacteriocin
To test the effect of different carbon and nitrogen sources
like glucose, lactose, yeast extract, peptone and beef extract
on production of antimicrobial peptides, 0.5% of each of
them added to minimal medium with following compo-
sition (g/l): Na2HPO4.2H2O, 7.9; KH2PO4, 3.0; NaCl, 0.5;
NH4Cl, 1.0; pH 7.2. The antimicrobial peptides production
was measured as zone of inhibition against indicator
strains. For the characterization of peptides, culture was
grown in 1000 ml of NB using 2 l flasks to obtain large
quantity of antimicrobial peptides. One percent (v/v) of
overnight grown culture of SK.DU.4 was inoculated to 1 l
of NB medium and grown for 24 h on a rotary shaker at
30°C. Subsequently cells were separated by centrifugation
(8000 rpm, 20 min at 4°C). The supernatant was mixed
with 2% (w/v) of Diaion HP-20 (Supelco, SigmaAldrich,
USA) resin and the antimicrobial peptide was eluted in
methanol. Methanol was evaporated using a rota vapour
(BUCHI Rota vapor R-200), the antimicrobial peptide was
redissolved in Milli-Q water and further purification was
achieved through reverse phase HPLC (1260 Infinity,
Agilent Technologies, USA) using a semi-preparative C18
column (Pursuit 10C18 250×21.2 mm). Acetonitrile and
0.1% TFA were used as mobile phase. The purified bacte-
riocin was tested for antimicrobial activity and applied on
Tricine-SDS-PAGE (16%)/6 M urea.
Mass spectrometry and peptide mass fingerprint analysis
Matrix-assisted laser desorption ionization (MALDI) was
used to primarily characterize the antimicrobial bacteriocin.
The lyophilized peptide was re-suspended in methanol and
4 μl of peptide solution was mixed with 4 μl of matrix
(CHCA, 10 mg/ml), 1.0 μl of this mixture solution was
spotted onto the MALDI 100 well stainless steel sample
plate and allowed to air dry prior to the MALDI analysis
(Mandal et al. 2009). To obtain MALDI mass spectra, a
Voyager time-of-flight mass spectrometer (Applied
Biosystem, USA), equipped with 337 nm N2 laser was used
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were recorded in positive ion linear mode. Reproducibility
of the spectrum was checked several times from separately
spotted samples. In order to carry out peptide mass finger-
print (pmf) analysis of the purified bacteriocin solution,
the sample was lyophilized and dissolved in 50 mM ammo-
nium bicarbonate (pH 8.0) buffer. Protein was reduced
with 0.1 M DTT at 56°C for 30 min and alkylated with
0.3 M iodoacetamide at room temperature for 15 min in
the dark as described by Dey et al. (2012). Subsequently,
the sample was subjected to digestion with trypsin at 37°C
for overnight. One microliter of the digested sample was
spotted directly onto a MALDI target plate and 1 μl of
CHCA matrix solution was applied on the sample spot
and allowed to air dry. Mass spectra of different peptide
fragments were acquired in positive ion reflector mode
with a mass range of 700–5000 Da after an average of 1000
laser shots. Data was uploaded into MASCOT (Matrix
Science, London, UK) database to search the protein iden-
tity. During database search the following parameters were
considered: database, NCBInr; maximum missed cleavages,
1; precursor tolerance, 0.2 Da; peptide charges, +1; mass,
monoisotopic.
In-gel activity assay for detection of bacteriocin activity
Tricine-sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis (Tricine-SDS-PAGE) was performed for anti-
microbial peptide using 16% polyacrylamide gel. The
purified and concentrated antimicrobial peptide was ap-
plied onto the gel in duplicate. After the electrophoresis,
a part of the gel along with molecular weight markers
was stained with Coomassie Brilliant Blue R-250 to
visualize the protein bands. Whereas the unstained part
of the gel was used for in situ detection of bacteriocin
activity upon fixing it in a mixture of 2-propanol, acetic
acid and H2O (25:10:65) for 15 min and washed with
sterile H2O for 30 min repeatedly. It was placed in a
sterile Petri dish, overlaid with 10 ml of soft agar (0.8%)
containing test strain S. aureus (about 106 cells/ml).
Determination of minimum inhibitory concentration
The MIC of antimicrobial peptide was evaluated for dif-
ferent strains by using a microtiter plate dilution assay.
Test strains grown to logarithmic phase under optimal
conditions (between 0.3-0.4 OD) and used for assay in
triplicates as described earlier (Singh et al. 2012). The
lowest concentration that inhibited growth of test strain
and did not show any increase in absorption after 48 h
incubation was considered as MIC.
Effect of pH, temperature and hydrolytic enzymes on
bacteriocin activity
The antimicrobial peptide was checked for tolerance to
different temperature, pH and proteases activity. Todetermine the tolerance to temperature and pH, the
purified peptide was incubated at different temperatures
such as 60°, 80°, 100° and 121°C for 15 min and pH
values between 2.0–12.0. Different proteolytic enzymes
including pepsin, trypsin, chymotrypsin, proteinase K
and pronase E were incubated with peptide for 6 h at
37°C and the activity was terminated by heating at 80°C
before the peptide was used for assay.
Extraction of lipopeptide
Lipopeptide was isolated from bacterial culture in a
combination of acid and solvent extraction procedure
following Vater et al. (2002). In brief, cells were removed
from the 24 h growing culture broth by centrifugation
(13,000 × g) for 15 min at 4°C. The supernatant was
adjusted to pH 2.0 by addition of concentrated HCl and
allowed to precipitate at 4°C for 16 h. Precipitate was
collected after centrifugation (13,000 × g) for 20 min at
4°C and extracted with methanol by stirring for 2 h. The
lipopeptide containing methanol was collected after
filtration and vacuum-dried.
Purification of lipopeptide
The extracted lipopeptide dissolved in methanol and frac-
tionated by reverse phase- HPLC (Agilent 1100 series)
with a ZORBAX 300-SB18 column (4.6 mm × 250 mm,
particle size 5 μm), at a flow rate of 1 ml/min. The solvent
system used was 0.1% aqueous TFA (A) and acetonitrile
containing 0.1% TFA (B). The gradient of solvent B used
to run the column was as follows: 0-60% for 0–45 min,
60-80% for 45–55 min and 80-100% for 55–60 min. The
elution from the column was monitored at 215 nm in a
diode array detector and all the peaks of HPLC chromato-
gram were collected using a fraction collector (GILSON,
France) coupled with the system. Collected fractions were
concentrated by speed vacuum and antimicrobial activity
was screened. The major fraction showing antibacterial
activity was re-chromatographed in the same column
under similar conditions, but solvent B was used as 100%
ACN with a gradient of 0-10% for 30 min. Peptide con-
centration was determined using the RP-HPLC conditions
and calibrated with surfactin (Sigma-Aldrich).
MALDI-TOF-MS and sequencing
The molecular mass of the purified active lipopeptide
fraction was analysed following the protocol described
above. For MS/MS sequencing, the peptide was incu-
bated with 10% NaOH in methanol at room temperature
for 16 h to cleave the lactone ring. The cleaved peptide
was lyophilized, again extracted with methanol and
allowed for mass spectrometry analysis. The spectra
were recorded in the post-source decay (PSD) ion mode
as an average of 100 laser shots with a grid voltage of
75%. The reflector voltage was reduced in 25% steps and
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delay time of 100 ns.
Fatty acid analysis by GC-MS
Acid hydrolysis of lipopeptide was performed by incu-
bating the peptide (5 mg) with 0.5 ml of 6 M HCl at
90°C for 18 h in sealed tubes. The fatty acids were
extracted with ether and esterified with 0.95 ml
methanol and 0.05 ml of 98% H2SO4 at 65°C for 6 h.
Fatty acid methyl esters were obtained after extraction
with n-hexane and analyzed by GC-MS with a Clarus 500
GC (PerkinElmer, USA). Helium was used as carrier gas at
a flow rate of 1.0 ml/min. The column temperature was
maintained at 120°C for 3 min and thereafter gradually
increased (8°C/min) to 260°C.
Results
Characterization of bacterial strain
A strain, designated SK.DU.4, has been shown to exhibit
antibacterial activity as revealed by the clearing zone assay
while screening. To this effect, we sought to investigate the
molecular basis of its antimicrobial activity. Initial efforts to
identify the strain by phenotypic characteristics revealed
that the strain SK.DU.4 was a Gram-positive, rod shaped,
endo-spore forming bacteria with positive reaction forFigure 1 Neighbour-joining phylogenetic tree based on 16S rRNA ge
strain SK.DU.4 and other members of the genus Bacillus. Bootstrap valcatalase activity and negative for oxidase activity. It pro-
duces amylase and proteases as revealed by starch and skim
milk hydrolyses. It grew between 10° to 50°C temperature.
Positive for methyl red and nitrate reduction but negative
for indole test and urea hydrolysis. All these phenotypic
properties are in agreement with members of the genus
Bacillus, known to produce diverse antimicrobial peptides.
In addition to the phenotypic identification, the BLAST
analysis of 16S rRNA gene sequence revealed significant
identity (99.8%) with B. subtilis subsp. inaquosorum, a
strain shown to produce surfactin-like lipopeptide. Further,
the neighbour joining phylogenetic tree constructed with
16S rRNA gene sequences of other members of the genus
Bacillus confirmed that strain SK.DU.4 belongs to genus
Bacillus as it formed a distinct cluster along with other sub-
species of B. subtilis (Figure 1). Although strain SK.DU.4
showed highest similarity with B. subtilis subsp. inaquo-
sorum, it formed a clade with B. subtilis subsp. spizizenii,
with low bootstrap value. Therefore, strain SK.DU.4 was
assigned as another strain of B. subtilis. The growth curve
analysis along with studies on antimicrobial production
indicates that the strain SK.DU.4 also produces a peptide
like antimicrobial substance during stationary growth phase
(Figure 2). Notably, there is a significant increase in anti-
microbial peptide production during 14 to 18 h and thene sequences, showing the phylogenetic relationship between
ues greater than 50% are given at the nodes.
Figure 2 Growth phase-dependent bacteriocin production by Bacillus subtilis strain SK.DU.4. While filled squares represent bacterial growth
as measured by absorbance at 600 nm, filled triangles indicate corresponding bacteriocin activity as determined by inhibition zone assay.
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measured by inhibition zone.Production and purification of antimicrobial peptide
Although the antimicrobial peptides were produced in
NB for large scale preparation, the influence of different
carbon and nitrogen sources on peptides production was
tested using minimal medium. As revealed by inhibition
zone, increased production of antimicrobial peptides was
observed with addition of beef extract (15 mm) followed
by the combination of glucose and yeast extract
(14 mm), and peptone (13 mm) after 24 h. The optimum
pH for the production of antimicrobial peptides was 7.2
and there was no significant change in pH was observed
during the production of antimicrobial peptides. The
bacteriocin-like peptide was extracted from CFB by
hydrophobic interaction chromatography using Diaion
HP-20 beads and purified by a combination of chroma-
tography techniques as described previously (Singh et al.
2012). Subsequently, the purified peptide was tested for
antimicrobial activity against an array of Gram-positive
and Gram-negative bacteria, yeasts and fungi strains
using well diffusion assays. Interestingly, the antimicro-
bial peptide shows antibacterial activity against Gram-
positive bacteria only, without a detectable effect against
yeast (Table 1). The influence of medium composition
for antimicrobial activity of the peptide was ruled out as
comparable results of antimicrobial activity of strain SK.
DU.4 obtained while grown on minimal medium.Characterization of bacteriocin-like peptide
The peptide obtained by affinity chromatography was puri-
fied by RP-HPLC and used to determine molecular mass
by MALDI-TOF analysis. Additionally, the antimicrobial
peptide obtained during the lipopeptide extraction (frac-
tion 4; Figure 3A) yielded single band in SDS-PAGE ana-
lysis (Figure 3B) and showed antimicrobial activity against
S. aureus in in-gel assay (Figure 3C). Therefore, it was also
included for mass determination. Both peptides showed
molecular mass of 5323.9 Da (+1) and 2621.4 Da (+2) of
antimicrobial peptide (Figure 4A), suggesting that it is a
bacteriocin-like peptide. Further, the bacteriocin-like pep-
tide was subjected to tryptic digestion. After tryptic diges-
tion, the pmf analysis was performed by Matrix Science
Mascot UK software, and significant (P< 0.05) result was
obtained. The analysis revealed that five peptide sequences
have similarity with the stretches of secreted lipoprotein
of Methylomicrobium album BG8 (Protein View: gi|
381152247) and displayed 70% coverage with a significant
homology (Figure 5).Inhibition spectrum and sensitivity of the bacteriocin-like
peptide
The antimicrobial peptide displayed a narrow spectrum ac-
tivity and was active against Gram-positive bacteria such as
L. monocytogenes (MTCC839), S. aureus (MTCC1430), S.
mutans (MTCC497) and M. luteus (MTCC106). The scan-
ning electron microscopy (SEM) of S. aureus (MTCC1430)
treated with 6.0 μM concentration of bacteriocin-like
Table 1 Inhibition spectrum of bacteriocin-like peptide








S. aureus MTCC1430 + + +
B. subtilis MTCC121 - + +
B. subtilis MTCC441 - - +
B. subtilis MTCC619 - - +
B. subtilis MTCC736 - + +
B. subtilis MTCC1427 - + +
B. subtilis MTCC2423 - + +
B. subtilis MTCC9878 - + +
L. monocytogenes MTCC839 + + +
S. mutans MTCC497 + - +
M. luteus MTCC106 + + +
E. coli MTCC1610 - - +
V. cholerae MTCC3904 - - +
P. aeruginosa MTCC1934 - - +
S. marcescens MTCC97 - - +
C. freundii MTCC1658 - - +
A. faecalis MTCC3104 - - +
A. baumannii MTCC1425 - - +
P. vulgaris MTCC1771 - - +
C. albicans MTCC1637 - - -
Asperigillus terreus Lab isolate - + -
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(Figure 4C). The MIC analysis of purified peptide revealed
S. aureus and L. monocytogenes are more sensitive strains
and are inhibited at lower concentrations of the peptide
compared to other test strains (Figure 6). No activity could
be detected when tested for other Gram-negative bacteriaFigure 3 Separation of the antimicrobial lipopeptide from acidic met
profile of acidic methanol extract showed four peaks (F1-F4) and among th
antimicrobial activity. Diagonal red line indicates the gradient of solvent B;
fraction (F2). (B) Tricine–SDS-PAGE of the purified bacteriocin-like peptide. (
zone against test strain S. aureus (indicated with arrow).included in the assay. The results of heat stability assay of
the antimicrobial peptide shows that the antimicrobial ac-
tivity is retained as high as 80°C for 15 min. Clearly, there
was sharp decrease in activity with increase in temperature
up to 100°C and no activity observed when the peptide
was autoclaved (121°C for 15 min). The peptide did not
show a change in its activity profile between pH 3.0 - 9.0,
however, the activity sharply reduced to almost undetec-
table level above pH 9.0. No activity was observed at pH
2.0 and 10.0. Significant decrease in antimicrobial activity
was observed when the peptide was incubated with pepsin,
trypsin, chymotrypsin, pronase E and proteinase K for 6 h.
Complete loss of antimicrobial activity was observed with
overnight incubation of the peptide with above proteases.
Interestingly, the antimicrobial peptide showed increase in
activity when combined with lipopeptide produced by
strain SK.DU.4 (Figure 4D).Lipopeptide purification and MS/MS sequencing
In contrast to bacteriocin-like peptide, the lipopeptide
from liquid culture-grown supernatant was extracted
as methanolic extract and separated using RP-HPLC.
Four fractions were observed during HPLC separation
(Figure 3A). After lyophilization, all fractions were tested
for antimicrobial activity and found that fractions 2 and
4 exhibiting antimicrobial activity. Fraction 4 was identi-
fied as bacteriocin-like peptide as described above and
fraction 2 showed a low molecular mass of 1056 Da
(Figure 4B). The primary structure elucidation of the
fraction 2 peptide was made using a combination of
mass spectrometry techniques. The peaks obtained for
different fragments at m/z 836, 721, 558, 444, 316, 219,
105 and 18 in MS/MS analysis revealed the lipopeptide
sequence as Asp-Tyr-Asn-Gln-Pro-Asn-Ser (Figure 7).
The C-terminal amino acid in peptide was linked tohanol extract by using reversed-phase HPLC. (A) Chromatogram
ese fractions F2 (lipopeptide) and F4 (bacteriocin-like peptide) showed
inset picture shows the re-chromatogram profile of lipopeptide
C) Direct overlay of the SDS-PAGE gel demonstrating a clear inhibition
Figure 4 MALDI-TOF mass spectrum of bacteriocin-like peptide (A) and lipopeptide (B) obtained by solvent extraction. Spectrum was
acquired in positive ion linear mode and reproducibility of the spectrum checked several times with different spots of same sample. (C) Scanning
electron micrograph of S. aureus MTCC1430 cells (I) without treatment of bacteriocin-like peptide and (II) after treatment with bacteriocin-like
peptide (6.0 μM) for 4 h. (D) Antibacterial activity of the peptides using well diffusion assay. After each peptide was serially diluted 100 μl of the
lowest dilution inhibiting test strain were used for bacteriocin-like peptide (B), lipopeptide (L) and 50 μl of same dilutions were used to check the
combined effect (B+L) on L. monocytogenes (I) and M. luteus (II). The bacteriocin-like peptide showed 14 and 12 mm inhibition zone for L.
monocytogenes and M. luteus respectively. Lipopeptide yielded 11 mm zone for both strains. However, additive effect of both peptides showed a
zone of 17 and 15 mm for L. monocytogenes and M. luteus respectively. Similar results were obtained in three individual experiments.
Figure 5 (A) Peptide mass fingerprinting (pmf) analysis of bacteriocin-like antimicrobial peptide (5324 Da). The pmf followed by
MASCOT (Matrix Science, London, UK) search shows the matched amino acid residues (in red bold) of the peptide fragments with the putative
periplasmic or secreted lipoprotein [Methylomicrobium album BG8] following NCBI blast search. (B) Amino acid sequence of the lipopeptide
obtained by solvent extraction.
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Figure 6 Determination of MIC for purified bacteriocin-like
antimicrobial peptide towards different Gram-positive indicator
strains. The micro-titre plate assay performed in triplicates revealed
that L. monocytogenes and S. aureus are highly sensitive.
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ring, a characteristic feature observed for cyclic lipopep-
tides. Based on the amino acid composition, fraction 2
lipopeptide was identified as member of the iturin family
biosurfactants with a mass value of m/z 1056 Da.
Discussion
Antimicrobial peptides are produced as defensin molecules
by many Gram-positive bacteria including Bacillus inFigure 7 MALDI TOF PSD (MS/ MS) spectrum of lipopeptide (fractioncomplex environments. Habitats like rhizosphere provide
competitive environment resulting in multiple strains pro-
ducing antimicrobial peptides that exhibit selective
spectrum of inhibition. In addition to antimicrobial pep-
tides, many strains of bacteria are reported to produce a
variety of antimicrobial biosurfactants like lipopeptide anti-
biotics, classified as iturins or surfactins (Chen and Hoover
2003). Screening and characterization of these novel anti-
microbial peptides has attracted attention of many
researchers due to their potential applications in thera-
peutic and food industry. Moreover, combined production
of antimicrobial peptide and bioactive lipopeptide by a sin-
gle strain can import additional benefits to the strain(s) for
commercial applications like food preservation. Likewise,
few strains of Bacillus subtilis known to produce various
antimicrobial peptides including lipopeptides with potential
applications (Toure et al. 2004; Chen et al. 2008) and in few
instances co-production of a variety of lipopeptides like sur-
factin/iturin or surfactin/mycosubtilin have been reported
from Bacillus sp. (Huang et al. 1993; Duitman et al. 1999).
However, co-production of bacteriocin-like antimicrobial
peptide and a lipopeptide has never been reported for any
strain of the genus Bacillus. In the present study, we report
a novel strain SK.DU.4, identified during screening of soil
bacteria for antimicrobial substances production, which
produces both bacteriocin-like peptide and lipopeptide.
Although strain SK.DU.4 showed highest similarity with B.
subtilis subsp. inaquosorum (99.8% similarity) during blast
search of 16S rRNA gene sequence, it differed in pheno-
typic properties such as presence of ellipsoidal endospore
and growth at 14% NaCl concentration with the closest2 obtained in RP-HPLC of solvent extract).
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addition, the lipopeptide molecular mass of strain SK.DU.4
differed with surfactin-like lipopeptide (1120.8 m/z) pro-
duced by B. subtilis subsp. inaquosorum (Rooney et al.
2009). Further characterization of the antimicrobial pep-
tides produced by strain SK.DU.4 revealed that it produced
a bacteriocin-like peptide and an iturin like lipopeptide.
Although production of multiple peptides by a single strain
imparts biotechnological potential to the producing micro-
organism, purification of the peptides involves additional
complications. However, the purification of bacteriocin like
antimicrobial peptide in this study was achieved by a com-
bination of size exclusion, affinity and reversed phase chro-
matography techniques as described previously (Singh et al.
2012). In contrast, the lipopeptides which exist as homolo-
gues with marginal differences in their physicochemical
properties (Wang et al. 2004) were solvent extracted from
liquid culture-grown supernatant (Vater et al. 2002) and
subsequently purified by reversed phase chromatography.
The pmf analysis of 5.3 kDa antimicrobial peptide
revealed high similarity with the lipoprotein of Methylo-
microbium album, a secreted hydrolytic enzyme that are
known to degrade the structural components of the cell
wall and thereby exhibiting antimicrobial activity
(Collmer and Keen 1986). Similarly, disintegration of
the cell wall might be the cause of antimicrobial activity of
the bacteriocin-like peptide as cell debris observed in the
surroundings of the treated cells (Figure 4C II). Neverthe-
less, no lipid moiety was detected in TLC experiments
carried out for the detection of total lipids of the anti-
microbial peptide. However, characteristics like the low-
molecular-weight, narrow spectrum antimicrobial activity
against Gram-positive bacteria, sensitivity to proteolytic
enzymes and resistance to high temperature identified
the peptide as a bacteriocin-like antimicrobial peptide
belonging to class II nonmodified peptides (Klaenhammer
1993). Strains of the genus Bacillus produces a wide variety
of bacteriocins that are encoded by a cluster of genes com-
prising structural, transportation, immunity, regulatory and
other genes required for post-translational modifications
(Le Marrec et al. 2000; Lee et al. 2009; Abriouel et al.
2011). Antimicrobial peptides produced by members of the
genus Bacillus are classified under both bacteriocins with
post-translational modifications and nonmodified anti-
microbial peptides (Abriouel et al. 2011). However, peptide
mass fingerprint analysis of the peptide in this study
yielded different fragments (Figure 6) and the bioinfor-
matic analysis of one of the largest peptide fragment se-
quence (KLFKEFINTPEPTWNDVEHLLKK) showed 34%
hydrophobicity. The motif –LFKEFI- at N-terminal site of
the sequence is interesting where KE, the hydrophilic resi-
dues are surrounded by hydrophobic residues (LF and FI)
are might be important for cell penetration and cell mem-
brane interaction. Furthermore, the presence of a bioactivelipopeptide peak in RP-HPLC analysis of solvent extract
(Figure 3A) revealed that the strain SK.DU.4 also produced
an antimicrobial surfactant. Antimicrobial lipopetides are
known to produce by various strains of B. subtilis and they
includes iturin, bacillomycin, mycosubtilin and fengycin
with molecular weight ranging between 1028–1084 Da and
exhibit strong antimicrobial activity towards many patho-
genic fungi (Vanittanakom et al. 1986; Duitman et al. 1999;
Yu et al. 2002; Chen et al. 2008). These amphipathic lipo-
peptides are non-ribosomal peptides biosynthesized by
large multi-enzymes called non-ribosomal peptide synthe-
tases (NRPSs) with modularly arranged catalytic domains
(Peypoux et al. 1999; Finking and Marahiel 2004). There-
fore, to probe the composition and activity of the isolated
lipopeptide, its primary structure was determined using a
combination of chemical reactions and a variety of mass
spectrometry techniques. Based on the presence of β-
hydroxy fatty acid moiety, hepta peptide and its amino acid
composition, the lipopeptide was identified as a member of
the iturin family. However, it exhibited stronger antibacte-
rial activity than antifungal activity when compared with
other members of the iturin family. Additionally, strain SK.
DU.4 contained aspartic acid (D) compared to asparagine
(N) in iturins and mycosubtilin in their N-terminal consen-
sus sequence Asx-Tyr-Asn. Though, the sequence of Asp-
Tyr-Asn was observed at N-terminal for bacillomycin
(Peypoux et al. 1986), it differed with lipopeptide of strain
SK.DU.4 in the composition of other amino acids. The
lipopeptide was not tested for any surfactant activity as
there are no hydrophobic amino acids observed in the
sequence. Lipopeptides easily bind to the bacterial surface
bilayer and alter the local lipid organizational linking on
negatively charged fatty acids resulting in restructuring of
the lipid bilayer and prevent cellular processes (Horn et al.
2012). The fatty acid moiety is also found to play an im-
portant role in antimicrobial activity of lipopeptides (Boeck
et al. 1989) and members of the iturin family lipopetides
including iturin A, bacillomycin D, bacillomycin F, bacillo-
mycin L and bacillomycin Lc, contained a β-hydroxy fatty
acid with 14 carbon chain length and inhibited different
species of fungi but exhibited limited activity against
bacteria (Vanittanakom et al. 1986; Zeriouh et al. 2011). In
comparison, the lipopeptide in this study contained a β-
hydroxy fatty acid of 15 carbon chain length and showed
stronger antibacterial activity. Although the lipopeptide
inhibited growth of B. subtilis (MTCC121), it did not
inhibit the growth of other B. subtilis strains including
producing strain SK.DU.4. Lipopeptide also inhibited the
growth of strains like S. mutans in combination with
bacteriocin-like peptide. Thus, the additive effect of both
peptides exhibited increase in antimicrobial activity against
Gram-positive bacteria.
In conclusion, strain designated as SK.DU.4, identified
as Bacillus subitlis produced two novel antimicrobial
Baindara et al. AMB Express 2013, 3:2 Page 10 of 11
http://www.amb-express.com/content/3/1/2peptides that are active against a variety of Gram-positive
bacteria. The co-production of these antimicrobial peptides
by strain SK.DU.4 increased its applications as a biocontrol
agent or in food preservation due to its high antimicrobial
activity against S. aureus and L. monocytogenes, which are
frequently connected to food spoilage.
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